On May 6 and 7, over 100 NAFLD stakeholders convened in Barcelona and online for the inaugural Innovations in NAFLD Care 2022 conference (#INCBCN.)
On May 6 and 7, over 100 NAFLD stakeholders convened in Barcelona and online for the inaugural Innovations in NAFLD Care 2022 conference (#INCBCN.)
Innovations in NAFLD Care conferece co-chair Jeff Lazarus joins Roger Green, Louise Campbell and Jörn Schattenberg to review conference goals and ask whether the agenda and participants put forth a vision of an integrated NAFLD Care pathway. This conversation centers around areas for controversy, including data-driven patient empowerment and what the proper name for this disease should be.
Innovations in NAFLD Care conferece co-chair Jeff Lazarus joins Roger Green, Louise Campbell and Jörn Schattenberg to review conference goals and ask whether the agenda and participants put forth a vision of an integrated NAFLD Care pathway.
Co-chair Jeff Lazarus joins the Surfers (including co-chair Jörn Schattenberg) to review last week’s Innovations in NAFLD Care 2022 conference PLUS Roger Green interviews one of the events’ speakers, Human Edge CEO Dr. Marcus Ranney
Patient advocates Achim Kautz and Andrew Scott join the Surfers to discuss the role of NAFLD patient advocacy in the Fatty Liver community. This conversation centers around the importance of taking action locally and enhancing communication across stakeholder groups if we are to keep increasing momentum over time.
This conversation between Donna Cryer, Louise Campbell and Roger Green focuses largely on NASH patient care and digital health issues. Listen to learn why Roger Green believes the liver (and particularly Fatty Liver) might benefit more from digital therapeutics than any other organ system.
Donna Cryer joins Louise Campbell and Roger Green to share three pieces of news: an NCQA paper on NASH; an American Heart Association paper on the link between NASH and heart disease, and the Global Liver Institute’s new “Liver Health is Public Health” campaign.
Jörn Schattenberg and Louise Campbell share their view about the “best” paths for NAFLD Care Delivery in major countries today.
Did you ever wonder why leaders believe the care continuum necessary to bring the NASH pandemic under control will require so many types of healthcare providers and such a broad effort?
